Cargando…

Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis

BACKGROUND: Parkinson’s disease (PD) is a multifaceted neurodegenerative disease. The optic nerve, as a window into the central nervous system (CNS), is known to be an important part of the CNS and can be detected non-invasively. With the widespread availability of optical coherence tomography (OCT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yu, Jie, Chuanhong, Wang, Jianwei, Liu, Ziqiang, Li, Yuanyuan, Hou, Xiaoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520292/
https://www.ncbi.nlm.nih.gov/pubmed/36186761
http://dx.doi.org/10.3389/fmed.2022.957700
_version_ 1784799590921273344
author Deng, Yu
Jie, Chuanhong
Wang, Jianwei
Liu, Ziqiang
Li, Yuanyuan
Hou, Xiaoyu
author_facet Deng, Yu
Jie, Chuanhong
Wang, Jianwei
Liu, Ziqiang
Li, Yuanyuan
Hou, Xiaoyu
author_sort Deng, Yu
collection PubMed
description BACKGROUND: Parkinson’s disease (PD) is a multifaceted neurodegenerative disease. The optic nerve, as a window into the central nervous system (CNS), is known to be an important part of the CNS and can be detected non-invasively. With the widespread availability of optical coherence tomography (OCT) devices, an increasing number of studies have paid attention to the neuropathological disorders in the retina of PD patients in recent years. However, it is still controversial whether OCT can be used as a complementary tool for PD diagnosis. METHODS: This review is registered with PROSPERO, number CRD42022301258. The Embase, PUBMED, and The Cochrane Library databases were independently retrieved by 2 investigators to identify relevant papers published from 1 January 2017 to 24 January 2022. These studies used OCT or OCTA to evaluate the difference in the retinal nerve fiber layer (RNFL) thickness, ganglion cell layer(GCL) thickness, macula thickness, Cup and disk area superficial retinal capillary plexus (SCP), and deep retinal capillary plexus(DCP). The standard mean difference (SMD) with the 95% confidence interval (CI) was pooled for continuous outcomes. RESULTS: In total, 26 studies had been enrolled in this meta-analysis with a total number of 2,790 eyes, including 1,343 eyes from the PD group along with 1,447 eyes from the HC group. The results revealed that the RNFL thickness (SMD: −0.53; 95%CI, −0.71∼−0.35; P < 0.00001), GCL thickness (SMD: −0.43; 95%CI, −0.66 to −0.19; P = 0.0003), macula thickness (SMD: −0.22; 95%CI, −0.22 to −0.11; P < 0.0001) were significantly thinner in patients with PD. The SCP (SMD: −0.61; 95%CI, −1.31to −0.10; P = 0.02) was significantly lower in PD patients. The DCP (SMD: −0.48; 95%CI, −1.02 to −0.06; P = 0.08) is lower in PD patients, but the difference was statistically insignificant. CONCLUSION: Retinal nerve fiber layer thickness, GCL thickness, macular thickness, and SVD of PD patients are lower than those of healthy control. OCT and OCTA could detect morphological retinal changes in PD and might be objective and reproducible auxiliary tools to assist clinician diagnosis. SYSTEMATIC REVIEW REGISTRATION: [https://www.crd.york.ac.uk/prospero/], identifier [CRD42022301258].
format Online
Article
Text
id pubmed-9520292
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95202922022-09-30 Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis Deng, Yu Jie, Chuanhong Wang, Jianwei Liu, Ziqiang Li, Yuanyuan Hou, Xiaoyu Front Med (Lausanne) Medicine BACKGROUND: Parkinson’s disease (PD) is a multifaceted neurodegenerative disease. The optic nerve, as a window into the central nervous system (CNS), is known to be an important part of the CNS and can be detected non-invasively. With the widespread availability of optical coherence tomography (OCT) devices, an increasing number of studies have paid attention to the neuropathological disorders in the retina of PD patients in recent years. However, it is still controversial whether OCT can be used as a complementary tool for PD diagnosis. METHODS: This review is registered with PROSPERO, number CRD42022301258. The Embase, PUBMED, and The Cochrane Library databases were independently retrieved by 2 investigators to identify relevant papers published from 1 January 2017 to 24 January 2022. These studies used OCT or OCTA to evaluate the difference in the retinal nerve fiber layer (RNFL) thickness, ganglion cell layer(GCL) thickness, macula thickness, Cup and disk area superficial retinal capillary plexus (SCP), and deep retinal capillary plexus(DCP). The standard mean difference (SMD) with the 95% confidence interval (CI) was pooled for continuous outcomes. RESULTS: In total, 26 studies had been enrolled in this meta-analysis with a total number of 2,790 eyes, including 1,343 eyes from the PD group along with 1,447 eyes from the HC group. The results revealed that the RNFL thickness (SMD: −0.53; 95%CI, −0.71∼−0.35; P < 0.00001), GCL thickness (SMD: −0.43; 95%CI, −0.66 to −0.19; P = 0.0003), macula thickness (SMD: −0.22; 95%CI, −0.22 to −0.11; P < 0.0001) were significantly thinner in patients with PD. The SCP (SMD: −0.61; 95%CI, −1.31to −0.10; P = 0.02) was significantly lower in PD patients. The DCP (SMD: −0.48; 95%CI, −1.02 to −0.06; P = 0.08) is lower in PD patients, but the difference was statistically insignificant. CONCLUSION: Retinal nerve fiber layer thickness, GCL thickness, macular thickness, and SVD of PD patients are lower than those of healthy control. OCT and OCTA could detect morphological retinal changes in PD and might be objective and reproducible auxiliary tools to assist clinician diagnosis. SYSTEMATIC REVIEW REGISTRATION: [https://www.crd.york.ac.uk/prospero/], identifier [CRD42022301258]. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9520292/ /pubmed/36186761 http://dx.doi.org/10.3389/fmed.2022.957700 Text en Copyright © 2022 Deng, Jie, Wang, Liu, Li and Hou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Deng, Yu
Jie, Chuanhong
Wang, Jianwei
Liu, Ziqiang
Li, Yuanyuan
Hou, Xiaoyu
Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis
title Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis
title_full Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis
title_fullStr Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis
title_full_unstemmed Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis
title_short Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis
title_sort evaluation of retina and microvascular changes in the patient with parkinson’s disease: a systematic review and meta-analysis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520292/
https://www.ncbi.nlm.nih.gov/pubmed/36186761
http://dx.doi.org/10.3389/fmed.2022.957700
work_keys_str_mv AT dengyu evaluationofretinaandmicrovascularchangesinthepatientwithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT jiechuanhong evaluationofretinaandmicrovascularchangesinthepatientwithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT wangjianwei evaluationofretinaandmicrovascularchangesinthepatientwithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT liuziqiang evaluationofretinaandmicrovascularchangesinthepatientwithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT liyuanyuan evaluationofretinaandmicrovascularchangesinthepatientwithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT houxiaoyu evaluationofretinaandmicrovascularchangesinthepatientwithparkinsonsdiseaseasystematicreviewandmetaanalysis